(b)(6) based on the available information, this event is deemed to be a serious injury.The post market trend analysis, subject matter expert (sme) review, clinical review, and marketing review indicate that a perception in specific markets has caused a consistent rate of complaints by the end user because there is no wear time requirement for the ostomy skin barrier.No further actions are required, and this complaint will be closed.Although physical samples were received, no evaluation will be conducted.This evaluation will be closed.This issue will be monitored through the post market product monitoring review process.No further information was available at the time of the report.Should additional information become available, a follow-up report will be submitted.Reported to the fda on november 17, 2016.(b)(4).
|
Complaint reported that the "end user experienced a decrease in wear time from 1 to 2 times per day or up to 2 days max.He states due to frequent wafer changes he developed a 25mm open area with a red wound base between 4 and 7 o'clock that has mild clear drainage.He reports treating the area using stomahesive powder and liquid bandage and the area is improving.He states this occurred with 10 wafers from this box, and 7 wafers from a different box, but same lot." no further details have been provided.
|